Entera Historical Income Statement

ENTX Stock  USD 2.33  0.05  2.10%   
Historical analysis of Entera Bio income statement accounts such as Selling General Administrative of 5.2 M or Total Revenue of 15.3 K can show how well Entera Bio performed in making a profits. Evaluating Entera Bio income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Entera Bio's future profits or losses.
 
Yuan Drop
 
Covid
Financial Statement Analysis is much more than just reviewing and examining Entera Bio latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Entera Bio is a good buy for the upcoming year.
  
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Entera Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
For more information on how to buy Entera Stock please use our How to Invest in Entera Bio guide.

About Entera Income Statement Analysis

Entera Bio Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Entera Bio shareholders. The income statement also shows Entera investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Entera Bio Income Statement Chart

At this time, Entera Bio's Depreciation And Amortization is fairly stable compared to the past year. Interest Expense is likely to rise to about 31.4 M in 2025, whereas Total Revenue is likely to drop slightly above 15.3 K in 2025.

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Entera Bio. It is also known as Entera Bio overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.

Total Operating Expenses

The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.
Most accounts from Entera Bio's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Entera Bio current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Entera Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
For more information on how to buy Entera Stock please use our How to Invest in Entera Bio guide.At this time, Entera Bio's Depreciation And Amortization is fairly stable compared to the past year. Interest Expense is likely to rise to about 31.4 M in 2025, whereas Total Revenue is likely to drop slightly above 15.3 K in 2025.
 2024 2025 (projected)
Interest Income854.5K696.3K
Reconciled Depreciation53.1K84.1K

Entera Bio income statement Correlations

0.310.55-0.44-0.47-0.540.61-0.530.54-0.480.24-0.48-0.560.990.560.01
0.310.860.02-0.83-0.850.48-0.860.86-0.820.14-0.82-0.820.220.580.09
0.550.86-0.4-0.94-0.980.86-0.981.0-0.930.19-0.93-0.970.450.710.0
-0.440.02-0.40.340.36-0.690.35-0.390.32-0.140.330.36-0.42-0.61-0.02
-0.47-0.83-0.940.340.94-0.790.94-0.940.990.120.990.94-0.39-0.68-0.03
-0.54-0.85-0.980.360.94-0.831.0-0.980.95-0.210.950.93-0.46-0.63-0.08
0.610.480.86-0.69-0.79-0.83-0.830.86-0.790.19-0.79-0.840.540.64-0.08
-0.53-0.86-0.980.350.941.0-0.83-0.980.95-0.20.950.93-0.45-0.63-0.08
0.540.861.0-0.39-0.94-0.980.86-0.98-0.930.19-0.93-0.970.440.710.01
-0.48-0.82-0.930.320.990.95-0.790.95-0.930.121.00.92-0.4-0.63-0.07
0.240.140.19-0.140.12-0.210.19-0.20.190.120.12-0.090.230.050.04
-0.48-0.82-0.930.330.990.95-0.790.95-0.931.00.120.92-0.4-0.64-0.08
-0.56-0.82-0.970.360.940.93-0.840.93-0.970.92-0.090.92-0.46-0.750.12
0.990.220.45-0.42-0.39-0.460.54-0.450.44-0.40.23-0.4-0.460.480.04
0.560.580.71-0.61-0.68-0.630.64-0.630.71-0.630.05-0.64-0.750.48-0.16
0.010.090.0-0.02-0.03-0.08-0.08-0.080.01-0.070.04-0.080.120.04-0.16
Click cells to compare fundamentals

Entera Bio Account Relationship Matchups

Entera Bio income statement Accounts

202020212022202320242025 (projected)
Depreciation And Amortization225K53K64K56K64.4K97.3K
Interest Expense84K1.4M29K26.0M29.9M31.4M
Selling General Administrative4.9M5.7M7.3M4.4M5.1M5.2M
Total Revenue365K571K134K14K16.1K15.3K
Gross Profit156K198K33K(56K)(50.4K)(47.9K)
Other Operating Expenses11.5M12.8M13.2M8.9M10.2M11.0M
Operating Income(11.1M)(12.2M)(13.0M)(8.9M)(8.0M)(8.4M)
Net Income From Continuing Ops(10.0M)(12.2M)(13.1M)(9.9M)(8.9M)(9.4M)
Ebit(11.1M)(12.2M)(13.0M)(8.9M)(8.0M)(8.4M)
Research Development6.4M6.8M5.8M4.5M5.1M5.7M
Ebitda(10.9M)(12.2M)(13.0M)(8.8M)(7.9M)(8.3M)
Cost Of Revenue209K373K101K56K64.4K116.0K
Total Operating Expenses11.3M12.4M13.1M8.9M10.2M10.9M
Income Before Tax(10.0M)(12.2M)(12.9M)(8.9M)(8.0M)(8.4M)
Total Other Income Expense Net1.2M(29K)83K31K27.9K26.5K
Net Income Applicable To Common Shares(10.8M)(10.0M)(12.2M)(13.1M)(11.8M)(12.4M)
Net Income(10.0M)(12.2M)(13.1M)(8.9M)(8.0M)(8.4M)
Income Tax Expense20K(59K)137K29K33.4K31.7K
Net Interest Income(67K)(29K)83K50K45K42.8K
Reconciled Depreciation225K53K64K59K53.1K84.1K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Entera Stock Analysis

When running Entera Bio's price analysis, check to measure Entera Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Entera Bio is operating at the current time. Most of Entera Bio's value examination focuses on studying past and present price action to predict the probability of Entera Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Entera Bio's price. Additionally, you may evaluate how the addition of Entera Bio to your portfolios can decrease your overall portfolio volatility.